ByteDance Explores Custom CPU Development to Power AI Expansion Regulatory Showdown States and Federal Regulators Clash Over Prediction Markets Standard Chartered Plans Significant Job Cuts in Corporate Functions to Boost Profitability Netflixs New Top Show Scores 95 on Rotten Tomatoes Bolstering Content Credentials From Fragile Promise to Identity The Decade That Reshaped American Soccers Financial Landscape Iran Intensifies Strategic Claims Over Strait of Hormuz with New Military Oversight Map Inhibikase Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines Barings BDC Inc BBDC Q1 2026 Earnings EPS Misses Estimates Amid Stable Market Conditions LIEN Q1 2026 Earnings Robust EPS Surprise of 2168 Highlights Strong Portfolio Performance ROST Q1 2026 Earnings EPS Beats Estimates by 145 Amid Cautious Consumer Environment DXCM Q1 2026 Earnings EPS Surges Past Estimates by 17 Amidst Market Skepticism FMNB Q1 2026 Earnings Strong EPS Surprise of 212 Drives Investor Attention Despite Stock Dip Atlantic American Corporation AAME Rises 14 as Shares Rebound From Key Support at 208 Unilever UL Slips Slightly Holds Near Key Support Amid Defensive Positioning Obsidian Energy OBE Slips 17 Amid Sector Pressure Holds Near Key Support XBiotech Inc XBIT Edges Higher Amid Steady Biotech Sector Activity DMC Global BOOM Surges 478 Key Levels and Market Dynamics BHVN Q1 2026 Earnings EPS Miss Amid Continued RD Investment LONA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development Euronet Worldwide EEFT Q1 2026 Earnings EPS Beat Drives Nuanced Outlook Amid Broader Market Headwinds LGL Q1 2026 Earnings Net Loss Misses Estimates Stock Edges Higher Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction UK Fiscal Debate The Untouchable Pension Triple Lock Amid IMF Spending Warnings Hillman Solutions Corp HLMN Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results Elicio Therapeutics ELTX Holds Near Resistance as Therapeutic Pipeline Momentum Builds